Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07076264 · ClinicalTrials.gov registry record · NA

Water Competency Intervention in Autism

A NA study of Autism Spectrum Disorders, sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT07076264: Recruiting NA study of Autism Spectrum Disorders, sponsored by Ohio State University.

NCT07076264 is a NA study of Autism Spectrum Disorders that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 108 participants, below the 163-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07076264, a NA study of Autism Spectrum Disorders, is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

AquOTic is an evidence-based, occupational therapy-led intervention designed to enhance water competency and swim safety skills in children on the autism spectrum. The 10-week program consists of weekly 60-minute group sessions, each including six children paired in a 1:1 ratio with an interventionist. Sessions follow a structured routine involving six rotating stations, targeting various swim and safety skills, with the flexibility for individualized support by the interventionist. Overall, this study has 3 major aims. The first aim evaluates the effectiveness of the AquOTic intervention in improving water competency and swim skills, while comparing outcomes between two implementation models: professional student interventionists (occupational and physical therapy students) and trained community-based interventionists. A total of 108 autistic children will be enrolled and randomly assigned to one of three groups: (1) AquOTic with professional student interventionists, (2) AquOTic with community interventionists, or (3) a control group receiving no AquOTic intervention. The second aim explores the mediators and moderators of the intervention outcomes to assess fidelity and efficacy. The third aim identifies the cost and resources associated with AquOTic. A cost analysis will be conducted to evaluate the resources required for implementation and to inform the development of a scalable, cost-effective drowning prevention strategy for autistic populations.

Primary Outcome

The WOTA2 measures a child's mental adaptation, adjustment to the pool, postural balance, and the ability to move and change position in the water, based on the Halliwick concept. WOTA2 assesses 27 swim skills scored on a 0-3 scale with a minimal detectable change score of 11.5. Higher scores indicate better skills. WOTA2 has high test-retest reliability (ICC=.97) and is validated for children with autism-like characteristics.

Conditions Studied

Interventions

  • OTHER AquOTic

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-09-19
Est. Completion 2029-04
Phase NA
Ohio State University

552 total trials

What NCT07076264 shows while recruiting

NCT07076264 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 163-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (34% lower).

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which AquOTic is the first listed.

NCT07076264 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07076264 about?

NCT07076264 is a clinical study titled "Water Competency Intervention in Autism". AquOTic is an evidence-based, occupational therapy-led intervention designed to enhance water competency and swim safety skills in children on the autism spectrum. The 10-week program consists of weekly 60-minute group sessions, each including six children paired in a 1:1 ratio with an interventioni...

What is the current status of trial NCT07076264?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-09-19. Estimated completion is 2029-04.

What conditions does trial NCT07076264 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

What interventions are being tested in trial NCT07076264?

The interventions under investigation include: AquOTic (OTHER).

Who is sponsoring clinical trial NCT07076264?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07076264 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07076264's enrollment target sits among peer trials

108 7th of 20 higher than 14 of 20 other Autism Spectrum Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07076264, the US trial registry maintained by the National Library of Medicine. NCT07076264 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.